XML 23 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements Of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net income (loss) $ 1,177,224,000 $ 881,242,000 $ (190,945,000)
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 437,324,000 409,937,000 363,027,000
Goodwill and long-lived asset impairment 0 19,247,000 654,084,000
Lower of cost or market inventory valuation adjustment 136,305,000 (108,685,000) (291,938,000)
Earnings of equity method investments, inclusive of distributions (149,000) 1,450,000 961,000
Loss on early extinguishment of debt attributable to unamortized discount/premium 0 2,475,000 8,718,000
Remeasurement gain on HEP pipeline interest acquisitions 0 (36,254,000) 0
Loss (gain) on sale of assets 2,171,000 508,000 (72,000)
Deferred income taxes 76,969,000 (137,522,000) 98,592,000
Equity-based compensation expense 42,172,000 42,337,000 25,561,000
Change in fair value – derivative instruments (31,515,000) (4,265,000) (12,155,000)
Excess tax expense from equity-based compensation 0 0 (4,209,000)
(Increase) decrease in current assets:      
Accounts receivable 35,793,000 (115,322,000) (127,221,000)
Inventories 136,551,000 (162,297,000) (1,869,000)
Income taxes receivable 7,752,000 50,601,000 (68,371,000)
Prepayments and other (10,340,000) (6,753,000) 16,555,000
Increase (decrease) in current liabilities:      
Accounts payable (326,030,000) 188,975,000 247,603,000
Income taxes payable 15,281,000 (18,525,000) (8,142,000)
Accrued liabilities 53,281,000 57,227,000 16,142,000
Turnaround expenditures (217,228,000) (135,104,000) (125,254,000)
Other, net 18,855,000 22,118,000 5,881,000
Net cash provided by operating activities 1,554,416,000 951,390,000 606,948,000
Cash flows from investing activities:      
Additions to properties, plants and equipment (256,888,000) (227,449,000) (372,195,000)
Purchase of Red Giant Oil, net of cash acquired (54,179,000) 0 0
Purchase of PCLI, net of cash acquired 0 (870,627,000) 0
Proceeds from sale of assets 3,100,000 1,377,000 849,000
Purchases of marketable securities 0 (41,565,000) (546,632,000)
Sales and maturities of marketable securities 0 465,716,000 266,603,000
Other, net 1,588,000 3,134,000 0
Net cash used for investing activities (360,520,000) (959,670,000) (801,597,000)
Cash flows from financing activities:      
Proceeds from issuance of senior notes 0 0 992,550,000
Proceeds from issuance of term loan - HFC 0 0 350,000,000
Repayment of term loan - HFC 0 0 (350,000,000)
Proceeds (repayments) of financing arrangements 32,547,000 0 (39,500,000)
Proceeds from issuance of common units - HEP 114,759,000 52,110,000 125,870,000
Purchase of treasury stock (363,437,000) (15,926,000) (138,107,000)
Dividends (233,544,000) (235,508,000) (234,004,000)
Distributions to noncontrolling interest (125,653,000) (110,351,000) (92,607,000)
Other, net 0 (13,955,000) (10,507,000)
Net cash provided by (used for) financing activities (664,328,000) (72,630,000) 838,695,000
Effect of exchange rate on cash flow (5,573,000) 1,088,000 0
Cash and cash equivalents:      
Increase (decrease) for the period 523,995,000 (79,822,000) 644,046,000
Beginning of period 630,757,000 710,579,000 66,533,000
End of period 1,154,752,000 630,757,000 710,579,000
Cash paid during the period for:      
Interest (130,106,000) (124,375,000) (54,074,000)
Income taxes, net (252,644,000) (93,272,000) (40,236,000)
HEP      
Cash flows from investing activities:      
Additions to properties, plants and equipment (54,141,000) (44,810,000) (107,595,000)
Purchase of pipeline interests, net of cash acquired - HEP 0 (245,446,000) (42,627,000)
Cash flows from financing activities:      
Borrowings under credit agreement 337,000,000 995,000,000 869,000,000
Repayments under credit agreement (426,000,000) (536,000,000) (1,028,000,000)
Proceeds from issuance of senior notes 0 101,750,000 394,000,000
Redemption of senior notes - HEP 0 (309,750,000) $ 0
Cash and cash equivalents:      
Beginning of period 7,776,000    
End of period $ 3,045,000 $ 7,776,000